PCDH10 and hepatocellular carcinoma: Treatment with the DNA methyltransferase inhibitor 5-aza-2’-deoxycytidine (Aza) restored PCDH10 mRNA expression by inhibiting promoter methylation, indicating that decreased PCDH10 expression is related to the promoter methylation status in HCC [62].